Last reviewed · How we verify
NCT05748444
The Relationship Between Diet and Glycemic Response and Inflammatory Markers in Children With Cystic Fibrosis
trial in Cystic Fibrosis in 24 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | büşra başpınar |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 24 |
| Start date | 1 January 2023 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Cystic Fibrosis — all drugs for Cystic Fibrosis →
- Glucose Metabolism Disorders — all drugs for Glucose Metabolism Disorders →
Sponsor
büşra başpınar
Who can join
Adults 6 to 18, any sex, with Cystic Fibrosis or Glucose Metabolism Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine the relationship between diets of children with cystic fibrosis and glycemic responses and some inflammatory markers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05748444
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cystic Fibrosis
Currently open trials in the same condition.
- NCT07437105 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants · Phase 1 · recruiting
- NCT07283770 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants · Phase 1 · recruiting
- NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
- NCT06810167 — Assessing Tenapanor as a Treatment of CF-related Constipation. · Phase 3 · recruiting
- NCT06962852 — A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI · Phase 1, PHASE2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05748444 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by büşra başpınar
- Last refreshed: 21 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748444.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing